It is important to incorporate DMPK assessment at very early stage of drug discovery to avoid expensive product development failures. The prediction of drug metabolism and pharmacokinetics in humans is the main role that DMPK plays in drug discovery. Cytovier has the capability to assess the properties associated with drug gastrointestinal absorption (for orally delivered therapies), distribution, clearance, elimination and DDI potential as rapidly and cost effectively as possible.

Cytovier is your partner to characterize your drug molecules at a very early stage and help you move to the next level quickly.